Cybułka Bartosz
Oddział Chirurgiczny z Pododdziałem Gastroenterologicznym Samodzielny Publiczny Zakład Opieki Zdrowotnej Kierownik Oddziału Chirurgicznego: lek. med. Andrzej Wach, Grodzisk Wielkopolski, Polska.
Pol Przegl Chir. 2017 Apr 30;89(2):11-25. doi: 10.5604/01.3001.0009.9162.
With current technological advancement and availability of synthetic materials used in inguinal hernia repair, a recurrence after first intervention is not a common and important adverse event. On the other hand, however, some patients complain about chronic pain of the operated site after surgeries using a polypropylene mesh. Many patients are constrained to a prolonged use of analgesics and increased frequency of control visits, which may eventually result in loss of trust in the operator. Every surgical intervention is associated with the risk of immediate or delayed complications. Genitofemoral neuralgia is associated with dysfunction of peripheral nerves passing through the inguinal canal or the surrounding tissue and it is a chronic, troublesome and undesired complication of an inguinal hernia repair. The possibility of minimizing chronic inguinal pain by proper management during herniorraphy should be considered in all cases of an inguinal canal reconstruction. The aim of the study was to investigate whether an intraoperative injection of 0.5% bupivacaine into the operated site (preemptive analgesia) has an influence on the postoperative pain assessed on the day of operation as well as the 1st and 2nd postoperative day after Lichtenstein hernioplasty of an inguinal, scrotal or recurrent hernia. In the studied population, we attempted to identify risk factors affecting pain level after surgical repair of an inguinal, scrotal or recurrent hernia.
During the period between December 2015 and May 2016, 133 patients with preoperative diagnosis of an inguinal (81.95%, n=109), scrotal (13.53%, n=18) or recurrent hernia (4.51%, n=6) underwent an elective intervention and were randomly allocated to the group, which intraoperatively received 20 mL of 0.5% bupivacaine locally in selected anatomical points of the inguinal canal. In the group with preoperative diagnosis of an inguinal hernia, this intervention was applied in 56.88% of cases (n=62). In the case of scrotal or recurrent hernia, a similar intervention was applied in 41.67% (n=10) of patients. During the hospital stay, pain was assessed four times a day using the NRS numeric scale. All patients received preoperative antibiotic prophylaxis, and, during observation, analgesics and low-molecular-weight heparin were used. In the studied group, risk factor were identified, which affect the pain level associated with surgical treatment of an inguinal hernia.
Mean pain level score according to the NRS scale (0-10) for an inguinal hernia was 4.17 on day 0 (standard deviation 2.22; minimum 0; maximum 10). On day 1 - 2.86 (standard deviation 1.86; minimum 0; maximum 8). On day 2 - 0.84 (standard deviation 1.21; minimum 0; maximum 5). The values of those parameters for a scrotal and recurrent hernia were as follows: on day 0 - 3.67 (standard deviation 1.76; minimum 0; maximum 7). On day 1 - 3.79 (standard deviation 1.67; minimum 0; maximum 7). On day 2 - 2.25 (standard deviation 1.54; minimum 0; maximum 4). Intraoperative application of 20 mL 0.5% bupivacaine did not reduce the postoperative pain on the postoperative day 0, 1, 2. Among independent risk factors exacerbating pain, the following variables were identified: local complications of the operated site including edema, ecchymosis and hematoma of the inguinal region. More frequent dressing changes were directly correlated with an increased pain sensation. Postoperative urethral catheterization due to urinary retention was associated with an increased pain immediately after surgery. In the case of intraoperative diagnosis of concurrent direct and indirect hernia (so-called pantaloon hernia), less intense pain was observed on postoperative day 0. Other parameters such as age, sex, duration of operation, duration of hospitalization and wound drainage did not influence the pain sensation.
Local injection of an analgesic into the operated site was not associated with the reduction of pain assessed on postoperative day 0, 1 and 2 after an isolated inguinal, scrotal or recurrent hernia repair. Pathologies of the operated site such as edema, ecchymosis or hematoma were associated with an increased pain sensations on observation. Also, postoperative urinary retention and urethral catheterization increased the pain sensation after an inguinal hernia repair. A lack of wound complications significantly decreased the pain sensation during the immediate postoperative period after hernia repair.
随着当前技术的进步以及腹股沟疝修补术中使用的合成材料的可得性,首次干预后复发并非常见且重要的不良事件。然而,另一方面,一些患者在使用聚丙烯网片进行手术后抱怨手术部位出现慢性疼痛。许多患者不得不长期使用镇痛药并增加复诊频率,这最终可能导致对手术医生失去信任。每次手术干预都伴随着即时或延迟并发症的风险。生殖股神经痛与穿过腹股沟管或周围组织的周围神经功能障碍有关,是腹股沟疝修补术的一种慢性、麻烦且不良的并发症。在所有腹股沟管重建病例中,都应考虑在疝修补术中通过适当管理将慢性腹股沟疼痛降至最低的可能性。本研究的目的是调查术中在手术部位注射0.5%布比卡因(超前镇痛)是否会对腹股沟、阴囊或复发性疝的Lichtenstein疝修补术后手术当天以及术后第1天和第2天评估的术后疼痛产生影响。在研究人群中,我们试图确定影响腹股沟、阴囊或复发性疝手术修复后疼痛程度的危险因素。
在2015年12月至2016年5月期间,133例术前诊断为腹股沟疝(81.95%,n = 109)、阴囊疝(13.53%,n = 18)或复发性疝(4.51%,n = 6)的患者接受了择期干预,并被随机分配到术中在腹股沟管选定解剖部位局部注射20 mL 0.5%布比卡因的组。在术前诊断为腹股沟疝的组中,56.88%(n = 62)的病例采用了这种干预。在阴囊疝或复发性疝的情况下,41.67%(n = 10)的患者采用了类似的干预。在住院期间,每天使用NRS数字量表评估疼痛4次。所有患者均接受术前抗生素预防,并且在观察期间使用了镇痛药和低分子量肝素。在研究组中,确定了影响腹股沟疝手术治疗相关疼痛程度的危险因素。
根据NRS量表(0 - 10),腹股沟疝患者在第0天的平均疼痛程度评分为4.17(标准差2.22;最小值0;最大值10)。在第1天为2.86(标准差1.86;最小值0;最大值8)。在第2天为0.84(标准差1.21;最小值0;最大值5)。阴囊疝和复发性疝的这些参数值如下:在第0天为3.67(标准差1.76;最小值0;最大值7)。在第1天为3.79(标准差1.67;最小值0;最大值7)。在第2天为2.25(标准差1.54;最小值0;最大值4)。术中应用20 mL 0.5%布比卡因并未降低术后第0天、第1天、第2天的术后疼痛。在加剧疼痛的独立危险因素中,确定了以下变量:手术部位的局部并发症,包括腹股沟区的水肿、瘀斑和血肿。更频繁的换药与疼痛感觉增加直接相关。因尿潴留进行的术后尿道插管与术后立即疼痛增加有关。在术中诊断为同时存在直疝和斜疝(所谓的马裤疝)的情况下,术后第0天观察到疼痛较轻。其他参数,如年龄、性别、手术持续时间、住院时间和伤口引流,均未影响疼痛感觉。
在单纯腹股沟、阴囊或复发性疝修补术后,在手术部位局部注射镇痛药与术后第0天、第1天和第2天评估的疼痛减轻无关。观察发现,手术部位的病变,如水肿、瘀斑或血肿,与疼痛感觉增加有关。此外,术后尿潴留和尿道插管会增加腹股沟疝修补术后的疼痛感觉。缺乏伤口并发症可显著降低疝修补术后即刻的疼痛感觉。